Share: Facebook Twitter LinkedIn
Activity Provided By:

i3 Health

Defining Personalized Care Plans in Metastatic Colorectal Cancer

Access Activity

Overview / Abstract:


Colorectal cancer (CRC) is the third leading cause of cancer death among men and women in the United States. An estimated 145,600 new cases are diagnosed annually and 51,020 people die of the disease. When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because CRC initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages. Approximately 21% of patients present with metastatic disease, which is associated with a 5-year survival rate of only 14%.


Medical oncologists, gastroenterologists, oncology advanced practitioners, and other health care professionals involved in the treatment of patients with CRC.


Upon completion of this activity, participants should be able to:

1.) Distinguish prognostic factors that can help tailor treatment to individual patients with metastatic CRC
2.) Evaluate recent study findings on novel therapies for newly diagnosed and relapsed/refractory metastatic CRC
3.) Assess strategies to optimize treatment experiences and ensure patient-centered metastatic CRC care


Tanios S. Bekaii-Saab, MD (Chairperson)
Professor of Medicine
Mayo Clinic Cancer Center


Oct 12, 2021


Nurse Practitioner , Physician CME, Physician Assistant CME


Webinar / Webcast / Video

Credits / Hours

1.0 CME, MOC



Presenters / Authors / Faculty

Tanios S. Bekaii-Saab, MD
Professor of Medicine
Mayo Clinic Cancer Center

Activity Specialities / Related Topics

Adverse Drug Reactions / ADR, Gastroenterology / GI, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Amgen.

Keywords / Search Terms

i3 Health i3 Health, CME, free CME, colorectal cancer, CRC, oncology, ILNA points, free CE, free CE CME Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map